| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Uesugi Motonari | 15 |
| #2 | Huff Joel | 15 |
| #3 | Kincaid John | 14 |
| #4 | Joel Huff | 1 |
| #5 | Motonari Uesugi | 1 |
| #6 | Cantrell Jr William R | 1 |
| #7 | John Kincaid | 1 |
| #8 | Abu-Elheiga Lutfi | 1 |
| #9 | Cantrell William R | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020132700A1 | Methods of using inhibitors of srebp in combination with niclosamide and analogs thereof | |
| EP3510027A1 | Di-substituted pyrazole compounds for the treatment of diseases | |
| MX2018013221A | Di-substituted pyrazole compounds for the treatment of diseases. | |
| US2018000801A1 | Compositions of fatostatin based heterocyclic compounds and uses thereof | |
| WO2016073826A1 | Synthesis of fatostatin based polycyclic compounds |